Merck Wins FDA Approval for New Cholesterol Pill

Merck & Co. won U.S. Food and Drug Administration approval for a pill version of its cholesterol drug, according to Bloomberg. Wall Street analysts have said the treatment could generate billions of dollars in annual sales.